Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: A review

Journal of Drugs in Dermatology

Volumn 10, Issue 5, 2011, Pages 539-544

  Kamili, Qurat Ul Ain ^a   Miner, Andrew ^b   Hapa, Asli ^c   Menter, Alan ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c Bolu Izzet Baysal State Hospital   (Turkey)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; INFLIXIMAB; LIVER ENZYME; METHOTREXATE; RETINOID; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY;

ABNORMAL LABORATORY RESULT; ACRODERMATITIS CONTINUA; ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ANEMIA; BILE DUCT CARCINOMA; BODY SURFACE; COMBINATION CHEMOTHERAPY; DENGUE; DIARRHEA; DISEASE SEVERITY; DISSEMINATED HISTOPLASMOSIS; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EAR INFECTION; EYE INFECTION; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HERPES ZOSTER; HISTOPLASMOSIS; HUMAN; HYPOPHYSIS DISEASE; IRITIS; KIDNEY FUNCTION; LEUKOCYTOSIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MOUTH ULCER; NAUSEA; OSTEOMYELITIS; PHOTOTHERAPY; PITUITARY ENLARGEMENT; PNEUMONIA; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RECALCITRANT PALMOPLANTAR PSORIASIS; REVIEW; SERUM SICKNESS LIKE ERUPTION; SIDE EFFECT; SKIN INFECTION; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URTICARIA; ARTICLE; DRUG COMBINATION; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051652166     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2008;58:826-850.
2. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD. Elevated tumor necrosis-alpha (TNF-α) biological activity in psoriatic skin lesions. Clin Exp Immunol. 1994;96:146-151. (Pubitemid 24213812)
3. Remicade [package insert]. Malvern, PA: Centocor Inc; 2007.
4. Reich K, Nestle FO, Papp K, et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. Lancet. 2005; 366:1367-1374. (Pubitemid 41443403)
5. Menter A, Feldman SR, Weinstein GD, et al. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol. 2007;56:31.e1-15. Epub September 6, 2006.
6. Cheifetz A, Smedley M, Martin S, et al. The incidence and management of infusion reactions to infliximab: A large center experience. Am J Gastroent. 2003;98:1315-1324. (Pubitemid 36741529)
7. Menter A, Reich K, Gottlieb AB, Bala M, Li S, Hsu MC, et al. Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations. J Drug Dermatol. 2008;7:1137-1146.
8. Griffiths CEM, Cristophers E, Barker JNWN, Chalmers RJG, Chimenti S, Krueger CL, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2006;156:258-262.
9. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3:55-78.
10. Warren RB, Brown BC, Carmichael AJ, Griffiths CEM. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate. Clin Exp Dermatol. 2009;34:415-416.
11. Krathen RA, Bertholet CN, Hsu S. Sustained efficacy and safety of infliximab in psoriasis: A retrospective study of 73 patients. J Drugs Dermatol. 2006;5:251-254.
12. Ogilvie AL, Antoni C, Dechant C, Manger B, Kalden JR, Schuler G, et al. Treatment of psoriatic arthritis with antitumour necrosis factor-a antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br J Dermatol. 2001;144:587-589. (Pubitemid 32232017)
13. Smith ECA, Riddle C, Menter MA, Lebwohl M. Combining systemic retinoids with biologic agents for moderate to severe psoriasis. Int J Dermatol. 2008;47:514-518. (Pubitemid 351560322)
14. Dalakar M, Bonesronning JH. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in retrospective cohort. J Eur Acad Dermatol Venereol. 2009;23:277-282.
15. Gach JE, Berth-Jones. Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea. J Dermatol Treat. 2003;14:226-228. (Pubitemid 37474534)
16. Barland C, Kerdel FA. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis. Arch Dermatol. 2003;14:226-228.